1
|
Fleming M, Huang Y, Dotson E, Bond DA, Reneau J, Epperla N, Alinari L, Brammer J, Christian B, Baiocchi RA, Maddocks K, Sawalha Y. A SINGLE‐CENTER RETROSPECTIVE ANALYSIS OF THE TOXICITY OF HIGH‐DOSE METHOTREXATE (HDMTX) ADMINISTERED ON THE FIRST DAY OF (R)CHOP IN AGGRESSIVE NONHODGKIN LYMPHOMAS (ANHLS). Hematol Oncol 2021. [DOI: 10.1002/hon.92_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- M Fleming
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - Y Huang
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - E Dotson
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - D. A Bond
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - J Reneau
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - N Epperla
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - L Alinari
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - J Brammer
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - B Christian
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - R. A Baiocchi
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - K Maddocks
- The Ohio State University Internal Medicine Columbus Ohio USA
| | - Y Sawalha
- The Ohio State University Internal Medicine Columbus Ohio USA
| |
Collapse
|
2
|
Gamberg M, Pratte I, Brammer J, Cuyler C, Elkin B, Gurney K, Kutz S, Larter NC, Muir D, Wang X, Provencher JF. Renal trace elements in barren-ground caribou subpopulations: Temporal trends and differing effects of sex, age and season. Sci Total Environ 2020; 724:138305. [PMID: 32272411 DOI: 10.1016/j.scitotenv.2020.138305] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/20/2020] [Revised: 03/25/2020] [Accepted: 03/27/2020] [Indexed: 06/11/2023]
Abstract
Caribou (Rangifer tarandus) are a culturally significant food resource for communities in northern Canada and Greenland. Many barren-ground caribou subpopulations are currently in decline, some dramatically; understanding the influence of stressors, such as toxic trace metals, is important. These contaminants enter Arctic terrestrial environments via atmospheric transport from industrialized areas and from local sources, accumulating there in the environment. Understanding how trace element concentrations interact and are influenced by caribou sex, age and season of collection is essential to evaluating trends in these elements over time and differences among subpopulations. We used path analysis to model the direct and indirect relationships between these variables in the Porcupine subpopulation and in barren-ground caribou from the Canadian Arctic and Greenland. Renal cadmium (Cd), copper (Cu) and mercury (Hg) varied significantly among subpopulations. Hg was positively correlated with Cd, Cu and selenium (Se) in female Porcupine caribou whereas Cd and Cu were negatively correlated in male Porcupine caribou. Age, season and sex influenced all three element concentrations and should be considered when comparing elements among caribou subpopulations or years. Renal Cd decreased slightly from the Canadian Western Arctic to Greenland and increased slightly over time, possibly reflecting patterns of atmospheric deposition. Renal Hg did not change significantly over time, and differences among subpopulations did not follow specific geographical patterns. Renal Cu declined over time, the changes being markedly different among subpopulations, sexes and seasons. This temporal decline is likely due to changes in diet, which could be driven by various environmental factors. Declining Cu concentrations in caribou is of concern as low levels could negatively affect reproductive success and therefore caribou at a population level. Continuing to monitor element concentrations in caribou is essential to better comprehend potential threats facing the species, and to promote food security in communities harvesting this important resource.
Collapse
Affiliation(s)
- M Gamberg
- Gamberg Consulting, Whitehorse, Canada.
| | - I Pratte
- Canadian Wildlife Service, Environment and Climate Change Canada, Gatineau, Canada
| | - J Brammer
- Science and Technology Branch, Environment and Climate Change Canada, Ottawa, Canada
| | - C Cuyler
- Greenland Institute of Natural Resources, Nuuk, Greenland
| | - B Elkin
- Government of the Northwest Territories Department of Environment and Natural Resources, Yellowknife, Canada
| | - K Gurney
- Science and Technology Branch, Environment and Climate Change Canada, Saskatoon, Canada
| | - S Kutz
- Faculty of Veterinary Medicine, University of Calgary, Calgary, Canada
| | - N C Larter
- Environment and Natural Resources, Government of Northwest Territories, Fort Simpson, Canada
| | - D Muir
- Science and Technology Branch, Environment and Climate Change Canada, Burlington, Canada
| | - X Wang
- Science and Technology Branch, Environment and Climate Change Canada, Burlington, Canada
| | - J F Provencher
- Canadian Wildlife Service, Environment and Climate Change Canada, Gatineau, Canada
| |
Collapse
|
3
|
Maakaron J, Zhao Q, Puto M, Von Derau R, Robinson J, Brammer J, Penza S, Baiocchi R, Christian B, Maddocks K, Saad A, Wall S, Benson D, Efebera Y, Rosko A, Ayyappan S, Grieselhuber N, Vasu S, Larkin K, Epperla N, Devarakonda S, Choe H, Chaudhry M, Blaser B, Blachly J, Bhatnagar B, Alinari L, Mims A, Jaglowski S, William B. PHASE I DOSE-ESCALATION STUDY OF VENETOCLAX PLUS BEAM FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR CHEMORESISTANT, RELAPSED/REFRACTORY, OR HIGH-RISK NON-HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS. Hematol Oncol 2019. [DOI: 10.1002/hon.213_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- J. Maakaron
- Hematology; The Ohio State University; Columbus United States
| | - Q. Zhao
- Hematology; The Ohio State University; Columbus United States
| | - M. Puto
- Hematology; The Ohio State University; Columbus United States
| | - R. Von Derau
- Hematology; The Ohio State University; Columbus United States
| | - J. Robinson
- Hematology; The Ohio State University; Columbus United States
| | - J. Brammer
- Hematology; The Ohio State University; Columbus United States
| | - S. Penza
- Hematology; The Ohio State University; Columbus United States
| | - R. Baiocchi
- Hematology; The Ohio State University; Columbus United States
| | - B. Christian
- Hematology; The Ohio State University; Columbus United States
| | - K. Maddocks
- Hematology; The Ohio State University; Columbus United States
| | - A. Saad
- Hematology; The Ohio State University; Columbus United States
| | - S. Wall
- Hematology; The Ohio State University; Columbus United States
| | - D. Benson
- Hematology; The Ohio State University; Columbus United States
| | - Y. Efebera
- Hematology; The Ohio State University; Columbus United States
| | - A. Rosko
- Hematology; The Ohio State University; Columbus United States
| | - S. Ayyappan
- Hematology; The Ohio State University; Columbus United States
| | - N. Grieselhuber
- Hematology; The Ohio State University; Columbus United States
| | - S. Vasu
- Hematology; The Ohio State University; Columbus United States
| | - K. Larkin
- Hematology; The Ohio State University; Columbus United States
| | - N. Epperla
- Hematology; The Ohio State University; Columbus United States
| | - S. Devarakonda
- Hematology; The Ohio State University; Columbus United States
| | - H. Choe
- Hematology; The Ohio State University; Columbus United States
| | - M. Chaudhry
- Hematology; The Ohio State University; Columbus United States
| | - B. Blaser
- Hematology; The Ohio State University; Columbus United States
| | - J. Blachly
- Hematology; The Ohio State University; Columbus United States
| | - B. Bhatnagar
- Hematology; The Ohio State University; Columbus United States
| | - L. Alinari
- Hematology; The Ohio State University; Columbus United States
| | - A. Mims
- Hematology; The Ohio State University; Columbus United States
| | - S. Jaglowski
- Hematology; The Ohio State University; Columbus United States
| | - B.M. William
- Hematology; The Ohio State University; Columbus United States
| |
Collapse
|
4
|
Horwitz S, Foss F, Porcu P, Moskowitz A, Mehta-Shah N, Jacobsen E, Khodadoust M, Kim Y, Weinstock D, Lustgarten S, Baglio M, Youssoufian H, Brammer J. Duvelisib, an oral dual PI3K-δ,γ inhibitor, efficacy and safety in patients with relapsed or refractory (RR) peripheral T-cell lymphoma: rationale for the phase 2 PRIMO trial. Hematol Oncol 2019. [DOI: 10.1002/hon.33_2629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- S.M. Horwitz
- Memorial Sloan Kettering Cancer Center; New York NY United States
| | - F.M. Foss
- Yale Cancer Center; New Haven CT United States
| | - P. Porcu
- Sidney Kimmel Cancer Center; Thomas Jefferson University; Philadelphia PA United States
| | - A. Moskowitz
- Memorial Sloan Kettering Cancer Center; New York NY United States
| | - N. Mehta-Shah
- Washington University Medical School; St. Louis MO United States
| | - E. Jacobsen
- Stanford Cancer Institute/School of Medicine; Stanford CA United States
| | - M.S. Khodadoust
- Stanford Cancer Institute/School of Medicine; Stanford CA United States
| | - Y.H. Kim
- Stanford Cancer Institute/School of Medicine; Stanford CA United States
| | - D. Weinstock
- Dana-Farber Cancer Institute; Boston MA United States
| | | | - M. Baglio
- Verastem Oncology, Inc; Needham MA United States
| | | | - J. Brammer
- Ohio State University; Columbus OH United States
| |
Collapse
|
5
|
Ai W, Vu K, Porcu P, Pincus L, Wieduwilt M, Kaplan L, Andreadis B, Brammer J. PHASE I STUDY OF ROMIDEPSIN AND LIPOSOMAL DOXORUBICIN IN RELAPSED OR REFRACTORY T-CELL LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.147_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- W. Ai
- Department of Medicine; University of California; San Francisco United States
| | - K. Vu
- Department of Medicine; University of California; San Francisco United States
| | - P. Porcu
- Department of Medicine; Ohio State University; Columbus United States
| | - L. Pincus
- Department of Medicine; University of California; San Francisco United States
| | - M. Wieduwilt
- Department of Medicine; University of California; San Diego United States
| | - L. Kaplan
- Department of Medicine; University of California; San Francisco United States
| | - B. Andreadis
- Department of Medicine; University of California; San Francisco United States
| | - J. Brammer
- Department of Medicine; Ohio State University; Columbus United States
| |
Collapse
|
6
|
William B, Abbasi A, Huang Y, Larbi R, Giali R, Yang L, Brammer J, Grantier C, Hoffman C, Ayyappan S, Baiocchi R, Epperla N, Christian B, Alinari L, Maddocks K, Chung C. A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMIDE (LEN) IN RELAPSED AND REFRACTORY (R/R) CUTANEOUS (CTCL) AND PERIPHERAL (PTCL) T-CELL LYMPHOMAS: PRELIMINARY RESULTS OF A PHASE II TRIAL. Hematol Oncol 2019. [DOI: 10.1002/hon.150_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- B.M. William
- Hematology; The Ohio State University; Columbus United States
| | - A. Abbasi
- Hematology; The Ohio State University; Columbus United States
| | - Y. Huang
- Hematology; The Ohio State University; Columbus United States
| | - R. Larbi
- Hematology; The Ohio State University; Columbus United States
| | - R. Giali
- Hematology; The Ohio State University; Columbus United States
| | - L. Yang
- Hematology; The Ohio State University; Columbus United States
| | - J. Brammer
- Hematology; The Ohio State University; Columbus United States
| | - C. Grantier
- Hematology; The Ohio State University; Columbus United States
| | - C. Hoffman
- Hematology; The Ohio State University; Columbus United States
| | - S. Ayyappan
- Hematology; The Ohio State University; Columbus United States
| | - R. Baiocchi
- Hematology; The Ohio State University; Columbus United States
| | - N. Epperla
- Hematology; The Ohio State University; Columbus United States
| | - B. Christian
- Hematology; The Ohio State University; Columbus United States
| | - L. Alinari
- Hematology; The Ohio State University; Columbus United States
| | - K. Maddocks
- Hematology; The Ohio State University; Columbus United States
| | - C. Chung
- Dermatology; The Ohio State University; Columbus United States
| |
Collapse
|
7
|
Porcu P, Haverkos B, Brem E, Vallurupalli A, Feldman T, Alpdogan O, Brammer J, Bryan L, Barta S, Schriefer A, Obrzut S, Shen H, Rochford R, Baiocchi R, Casper C, Gutheil J, Melink T, Kearns C, Burner D, McRae R, Daniels P, Warren M, Woody J, Royston I, Faller D. A PHASE 1B/2 STUDY OF ORAL NANATINOSTAT (N) AND VALGANCICLOVIR (VG) IN SUBJECTS WITH EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED LYMPHOMAS. Hematol Oncol 2019. [DOI: 10.1002/hon.148_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- P. Porcu
- Medical Oncology and Hematopoietic Stem Cell Transplantation; Thomas Jefferson University; Philadelphia United States
| | - B. Haverkos
- Hematology; University of Colorado School of Medicine; Aurora United States
| | - E. Brem
- Hematology/Oncology; University of California Irvine; Orange United States
| | - A. Vallurupalli
- Hematologic Malignancies and Cellular Therapeutics; University of Kansas Medical Center; Kansas City United States
| | - T. Feldman
- Hematology & Oncology; John Theurer Cancer Center; Hackensack United States
| | - O. Alpdogan
- Medical Oncology and Hematopoietic Stem Cell Transplantation; Thomas Jefferson University; Philadelphia United States
| | - J. Brammer
- Hematology; Ohio State University; Columbus United States
| | - L.J. Bryan
- Oncology; Augusta University; Augusta United States
| | - S. Barta
- Hematology; University of Pennsylvania; Philadelphia United States
| | - A. Schriefer
- Oncologia; Clinica Cehon; Canela Salvador Brazil
| | - S. Obrzut
- Radiology; University of California San Diego; La Jolla United States
| | - H. Shen
- Microbiology; University of Pennsylvania; Philadelphia United States
| | - R. Rochford
- Immunology & Microbiology; University of Colorado; Aurora United States
| | - R. Baiocchi
- Hematology; Ohio State University; Columbus United States
| | - C. Casper
- Research; Infectious Disease Research Institute; Seattle United States
| | - J. Gutheil
- SciQuus Oncology Inc; La Jolla United States
| | - T. Melink
- SciQuus Oncology Inc; La Jolla United States
| | - C. Kearns
- SciQuus Oncology Inc; La Jolla United States
| | - D. Burner
- SciQuus Oncology Inc; La Jolla United States
| | - R. McRae
- Viracta Therapeutics; Cardiff United States
| | - P. Daniels
- Viracta Therapeutics; Cardiff United States
| | | | - J. Woody
- Latterell Venture Partners; San Francisco United States
| | - I. Royston
- Viracta Therapeutics; Cardiff United States
| | - D. Faller
- Hematology & Medical Oncology; Boston University School of Medicine; Boston United States
| |
Collapse
|
8
|
Maakaron J, Huang Y, Brammer J, Chung C, William B. A phase II trial of brentuximab vedotin (BV) and lenalidomide (Len) in relapsed and refractory (r/r) cutaneous (CTCL) and peripheral (PTCL) T-cell lymphomas. Eur J Cancer 2019. [DOI: 10.1016/s0959-8049(19)30587-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
9
|
Waller A, Lundberg J, Porter K, Hwang S, Hastings J, Haverkos B, Brammer J, Fabbro S, William B, Dotson E, Porcu P. GEMCITABINE PLUS LIPOSOMAL DOXORUBICIN FOR RELAPSED REFRACTORY T-CELL LYMPHOMAS. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_166] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- A. Waller
- Department of Pharmacy; The James Cancer Hospital and Solove Research Institute at The Ohio State University; Columbus USA
| | - J. Lundberg
- Department of Pharmacy; The James Cancer Hospital and Solove Research Institute at The Ohio State University; Columbus USA
| | - K. Porter
- Center for Biostatistics; The Ohio State University; Columbus USA
| | - S. Hwang
- Division of Hematology; The James Cancer Hospital and Solove Research Institute at The Ohio State University; Columbus USA
| | - J. Hastings
- Division of Dermatology; The James Cancer Hospital and Solove Research Institute at The Ohio State University; Columbus USA
| | - B. Haverkos
- Division of Hematology; University of Colorado School of Medicine; Aurora USA
| | - J. Brammer
- Division of Hematology; The James Cancer Hospital and Solove Research Institute at The Ohio State University; Columbus USA
| | - S. Fabbro
- Division of Dermatology; The James Cancer Hospital and Solove Research Institute at The Ohio State University; Columbus USA
| | - B.M. William
- Division of Hematology; The James Cancer Hospital and Solove Research Institute at The Ohio State University; Columbus USA
| | - E. Dotson
- Department of Pharmacy; The James Cancer Hospital and Solove Research Institute at The Ohio State University; Columbus USA
| | - P. Porcu
- Division of Hematologic Malignancies; Sidney Kimmel Cancer Center at Jefferson; Philadelphia USA
| |
Collapse
|
10
|
Liaw SY, Chen FG, Klainin P, Brammer J, O'Brien A, Samarasekera DD. Developing clinical competency in crisis event management: an integrated simulation problem-based learning activity. Adv Health Sci Educ Theory Pract 2010; 15:403-13. [PMID: 19916052 DOI: 10.1007/s10459-009-9208-9] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2008] [Accepted: 11/02/2009] [Indexed: 05/14/2023]
Abstract
This study aimed to evaluate the integration of a simulation based learning activity on nursing students' clinical crisis management performance in a problem-based learning (PBL) curriculum. It was hypothesized that the clinical performance of first year nursing students who participated in a simulated learning activity during the PBL session would be superior to those who completed the conventional problem-based session. The students were allocated into either simulation with problem-based discussion (SPBD) or problem-based discussion (PBD) for scenarios on respiratory and cardiac distress. Following completion of each scenario, students from both groups were invited to sit an optional individual test involving a systematic assessment and immediate management of a simulated patient facing a crisis event. A total of thirty students participated in the first post test related to a respiratory scenario and thirty-three participated in the second post test related to a cardiac scenario. Their clinical performances were scored using a checklist. Mean test scores for students completing the SPBD were significantly higher than those who completing the PBD for both the first post test (SPBD 20.08, PBD 18.19) and second post test (SPBD 27.56, PBD 23.07). Incorporation of simulation learning activities into problem-based discussion appeared to be an effective educational strategy for teaching nursing students to assess and manage crisis events.
Collapse
Affiliation(s)
- S Y Liaw
- Alice Lee Centre for Nursing Studies, National University of Singapore, Singapore.
| | | | | | | | | | | |
Collapse
|
11
|
Brammer J, Finn R, Bell WH, Sinn D, Reisch J, Dana K. Stability after bimaxillary surgery to correct vertical maxillary excess and mandibular deficiency. J Oral Surg 1980; 38:664-70. [PMID: 6931887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|